Successful topical application of a new antifungal agent, micafungin, in the treatment of refractory fungal corneal ulcers: Report of three cases and literature review

Yukihiro Matsumoto, Murat Dogru, Eiki Goto, Hiroshi Fujishima, Kazuo Tsubota

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Purpose: To report the efficacy of topical application of a new antifungal agent, micafungin (MCFG), in the treatment of yeast-related corneal ulcers. Design: Noncomparative interventional case reports. Participants: Three patients with yeast-related corneal ulcer after keratoplasty recalcitrant to conventional antifungal treatment for 4 weeks were recruited in this study. Methods: Topical 0.1% antifungal MCFG eye drops were applied in 3 patients with yeast-related corneal ulcer every hour while awake until epithelialization. After epithelialization, the frequency of eye drops was reduced to 5 times a day. MCFG eye drops were discontinued 1 month after the disappearance of stromal infiltration in each case. The patients underwent best corrected visual acuity (BCVA) measurements, slit-lamp examination, ftuorescein-dye staining, and anterior segment photography. Corneal scrapings and cultures of surgical materials were also performed. Main Outcome Measures: Changes in ulcer size, stromal infiltration, fluorescein dye staining, and BCVA were looked for. Results: All corneal ulcers epithelialized within 14 days after commencement of application of 0.1% MCFG eye drops. Yeasts were detected from corneal smears in all eyes. Two cases revealed positive culture isolates for Candida albicans and Candida parapsilosis. No recurrence of fungal keratitis was observed in any of the cases throughout the follow-up periods. Conclusion: Topical 0.1% MCFG eye drops seem to be an effective and a promising option in the treatment of refractory yeast-related corneal ulcers.

Original languageEnglish
Pages (from-to)748-753
Number of pages6
JournalCornea
Volume24
Issue number6
DOIs
Publication statusPublished - 2005 Aug

Fingerprint

Corneal Ulcer
Ophthalmic Solutions
Antifungal Agents
Yeasts
Visual Acuity
Coloring Agents
Staining and Labeling
Therapeutics
Corneal Transplantation
Keratitis
Photography
Fluorescein
Candida albicans
Candida
Ulcer
Outcome Assessment (Health Care)
micafungin
Recurrence

Keywords

  • Corneal ulcer
  • Micafungin
  • Yeast

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Successful topical application of a new antifungal agent, micafungin, in the treatment of refractory fungal corneal ulcers : Report of three cases and literature review. / Matsumoto, Yukihiro; Dogru, Murat; Goto, Eiki; Fujishima, Hiroshi; Tsubota, Kazuo.

In: Cornea, Vol. 24, No. 6, 08.2005, p. 748-753.

Research output: Contribution to journalArticle

@article{277f8514738a47548158c6070dd95396,
title = "Successful topical application of a new antifungal agent, micafungin, in the treatment of refractory fungal corneal ulcers: Report of three cases and literature review",
abstract = "Purpose: To report the efficacy of topical application of a new antifungal agent, micafungin (MCFG), in the treatment of yeast-related corneal ulcers. Design: Noncomparative interventional case reports. Participants: Three patients with yeast-related corneal ulcer after keratoplasty recalcitrant to conventional antifungal treatment for 4 weeks were recruited in this study. Methods: Topical 0.1{\%} antifungal MCFG eye drops were applied in 3 patients with yeast-related corneal ulcer every hour while awake until epithelialization. After epithelialization, the frequency of eye drops was reduced to 5 times a day. MCFG eye drops were discontinued 1 month after the disappearance of stromal infiltration in each case. The patients underwent best corrected visual acuity (BCVA) measurements, slit-lamp examination, ftuorescein-dye staining, and anterior segment photography. Corneal scrapings and cultures of surgical materials were also performed. Main Outcome Measures: Changes in ulcer size, stromal infiltration, fluorescein dye staining, and BCVA were looked for. Results: All corneal ulcers epithelialized within 14 days after commencement of application of 0.1{\%} MCFG eye drops. Yeasts were detected from corneal smears in all eyes. Two cases revealed positive culture isolates for Candida albicans and Candida parapsilosis. No recurrence of fungal keratitis was observed in any of the cases throughout the follow-up periods. Conclusion: Topical 0.1{\%} MCFG eye drops seem to be an effective and a promising option in the treatment of refractory yeast-related corneal ulcers.",
keywords = "Corneal ulcer, Micafungin, Yeast",
author = "Yukihiro Matsumoto and Murat Dogru and Eiki Goto and Hiroshi Fujishima and Kazuo Tsubota",
year = "2005",
month = "8",
doi = "10.1097/01.ico.0000154390.28254.54",
language = "English",
volume = "24",
pages = "748--753",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Successful topical application of a new antifungal agent, micafungin, in the treatment of refractory fungal corneal ulcers

T2 - Report of three cases and literature review

AU - Matsumoto, Yukihiro

AU - Dogru, Murat

AU - Goto, Eiki

AU - Fujishima, Hiroshi

AU - Tsubota, Kazuo

PY - 2005/8

Y1 - 2005/8

N2 - Purpose: To report the efficacy of topical application of a new antifungal agent, micafungin (MCFG), in the treatment of yeast-related corneal ulcers. Design: Noncomparative interventional case reports. Participants: Three patients with yeast-related corneal ulcer after keratoplasty recalcitrant to conventional antifungal treatment for 4 weeks were recruited in this study. Methods: Topical 0.1% antifungal MCFG eye drops were applied in 3 patients with yeast-related corneal ulcer every hour while awake until epithelialization. After epithelialization, the frequency of eye drops was reduced to 5 times a day. MCFG eye drops were discontinued 1 month after the disappearance of stromal infiltration in each case. The patients underwent best corrected visual acuity (BCVA) measurements, slit-lamp examination, ftuorescein-dye staining, and anterior segment photography. Corneal scrapings and cultures of surgical materials were also performed. Main Outcome Measures: Changes in ulcer size, stromal infiltration, fluorescein dye staining, and BCVA were looked for. Results: All corneal ulcers epithelialized within 14 days after commencement of application of 0.1% MCFG eye drops. Yeasts were detected from corneal smears in all eyes. Two cases revealed positive culture isolates for Candida albicans and Candida parapsilosis. No recurrence of fungal keratitis was observed in any of the cases throughout the follow-up periods. Conclusion: Topical 0.1% MCFG eye drops seem to be an effective and a promising option in the treatment of refractory yeast-related corneal ulcers.

AB - Purpose: To report the efficacy of topical application of a new antifungal agent, micafungin (MCFG), in the treatment of yeast-related corneal ulcers. Design: Noncomparative interventional case reports. Participants: Three patients with yeast-related corneal ulcer after keratoplasty recalcitrant to conventional antifungal treatment for 4 weeks were recruited in this study. Methods: Topical 0.1% antifungal MCFG eye drops were applied in 3 patients with yeast-related corneal ulcer every hour while awake until epithelialization. After epithelialization, the frequency of eye drops was reduced to 5 times a day. MCFG eye drops were discontinued 1 month after the disappearance of stromal infiltration in each case. The patients underwent best corrected visual acuity (BCVA) measurements, slit-lamp examination, ftuorescein-dye staining, and anterior segment photography. Corneal scrapings and cultures of surgical materials were also performed. Main Outcome Measures: Changes in ulcer size, stromal infiltration, fluorescein dye staining, and BCVA were looked for. Results: All corneal ulcers epithelialized within 14 days after commencement of application of 0.1% MCFG eye drops. Yeasts were detected from corneal smears in all eyes. Two cases revealed positive culture isolates for Candida albicans and Candida parapsilosis. No recurrence of fungal keratitis was observed in any of the cases throughout the follow-up periods. Conclusion: Topical 0.1% MCFG eye drops seem to be an effective and a promising option in the treatment of refractory yeast-related corneal ulcers.

KW - Corneal ulcer

KW - Micafungin

KW - Yeast

UR - http://www.scopus.com/inward/record.url?scp=23044499954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23044499954&partnerID=8YFLogxK

U2 - 10.1097/01.ico.0000154390.28254.54

DO - 10.1097/01.ico.0000154390.28254.54

M3 - Article

C2 - 16015098

AN - SCOPUS:23044499954

VL - 24

SP - 748

EP - 753

JO - Cornea

JF - Cornea

SN - 0277-3740

IS - 6

ER -